Potential heart attack drug without side effects under development

A team of scientists combining molecular pharmacology and medicinal chemistry reveal new insights into a specific protein belonging to the family of G protein-coupled receptors (GPCRs). After successfully combining two molecules, they are a step closer to creating a brand new class of drug that is more targeted and could possess minimal side effects.

Read the whole article on Science Daily

More from Science Daily